CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis. (Q50484927)

14 March 2018

http://europepmc.org/abstract/MED/24111625

title

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis. (English)

1 reference

14 March 2018

http://europepmc.org/abstract/MED/24111625

0 references

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

María Jara-acevedo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Andrés García-Montero

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Omar Perbellini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Almudena Matito

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Iván Alvarez-Twose

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Manuela Mollejo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Tracy I George

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Laura Sanchez-Muñoz

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

15

Alberto Orfao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

José M Morgado

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ryan C Johnson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Cristina Teodósio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Patrizia Bonadonna

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Andrea Mayado

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Roberta Zanotti

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Luis Escribano

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

20 September 2013

1 reference

14 March 2018

http://europepmc.org/abstract/MED/24111625

published in

Histopathology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

780-787

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24111625%20AND%20SRC:MED&resulttype=core&format=json

Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.

1 June 2020

cites work

1 reference

Diagnostic criteria and classification of mastocytosis: a consensus proposal

21 January 2018

1 reference

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria

21 January 2018

1 reference

Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis

21 January 2018

1 reference

Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms.

21 January 2018

1 reference

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

21 January 2018

1 reference

CD30 in normal and neoplastic cells.

21 January 2018

1 reference

Extremely rapid and intense induction of apoptosis in human eosinophils by anti-CD30 antibody treatment in vitro

21 January 2018

1 reference

Evaluation of the WHO criteria for the classification of patients with mastocytosis.

21 January 2018

1 reference

Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.

21 January 2018

1 reference

Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders

21 January 2018

1 reference

Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA).

21 January 2018

1 reference

Selecting fluorochrome conjugates for maximum sensitivity

21 January 2018

1 reference

Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.

21 January 2018

1 reference

A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib

21 January 2018

1 reference

Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.

21 January 2018

1 reference

CD30-targeted antibody therapy

21 January 2018

1 reference

Brentuximab vedotin in anaplastic large cell lymphoma

21 January 2018

1 reference

21 January 2018

1 reference